gusperimus - CISMeF

Preferred Label : gusperimus;

MeSH note : synthesized by chemical modification of spergualin; in combination with cyclosporin A prevents diabetes in predisposed NOD mice; structure given in first source; RN given refers to (-)-isomer trihydrochloride;

CISMeF synonym : NKT-01; deoxyspergualin;

Related MeSH term : 1-amino-19-guanidino-11-hydroxy-4,9,12-triazanonadecane-10,13-dione; 15-deoxyspergualin;

MeSH CAS label : heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-;

MeSH Related Number : gusperimus trihydrochloride; gusperimus, ( -)-isomer; 104317-84-2 (( -)-isomer); 85468-01-5 (3HCl); 57F9XM233R; 84937-45-1 (gusperimus); 85468-01-5 (gusperimus trihydrochloride); QZS4144IO0;

Registry Number MeSH : 84937-45-1;

Related CAS MeSH : 85468-01-5 (gusperimus trihydrochloride); 104317-84-2 (gusperimus, ( -)-isomer);

related registry number list (CISMeF) : 104317-84-2 (( -)-isomer); 85468-01-5 (3HCl);

Is substance : O;

UNII : UJ0ZJ76DO9;

Details

Origin ID

C037258;

UMLS CUI

C0284559;

ATC code(s)
- gusperimus [ATC Code]
Currated CISMeF NLP mapping
- Gusperimus [NCIt concept]
MeSH term(s) associated for indexing
- guanidines [MeSH Descriptor]
Pharmacological action(s)
- antibiotics, antineoplastic [MeSH Descriptor]
- hypoglycemic agents [MeSH Descriptor]
- immunosuppressive agents [MeSH Descriptor]
- radiation-protective agents [MeSH Descriptor]
Record concept(s)
- NKT-01 [MeSH concept]
- deoxyspergualin [MeSH concept]
- gusperimus [MeSH concept]
- gusperimus trihydrochloride [MeSH concept]
- gusperimus, (+-)-isomer [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Gusperimus [NCIt concept]
- gusperimus [ATC Code]
Validated automatic mappings to BTNT
- Gusperimus Trihydrochloride [NCIt concept]
- gusperimus [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients